This is a visual explainer based on the Wikipedia article on PUVA therapy. Read the full source article here. (opens in new tab)

Illuminating Skin Health

An in-depth exploration of PUVA (Psoralen + UVA) therapy, detailing its mechanisms, applications in treating skin conditions like psoriasis and vitiligo, historical context, and potential side effects.

What is PUVA? ๐Ÿ‘‡ Explore Procedure โš™๏ธ

Dive in with Flashcard Learning!


When you are ready...
๐ŸŽฎ Play the Wiki2Web Clarity Challenge Game๐ŸŽฎ

Overview

Photochemotherapy Defined

PUVA therapy is a specialized form of ultraviolet light treatment employed for various dermatological conditions. It combines the administration of a photosensitizing agent, psoralen, with exposure to ultraviolet A (UVA) light.[1][2][3] This synergistic approach is particularly effective for conditions such as vitiligo, eczema, psoriasis, graft-versus-host disease, mycosis fungoides, large plaque parapsoriasis, and cutaneous T-cell lymphoma.

Mechanism of Action

Psoralens, whether ingested orally or applied topically, render the skin significantly more sensitive to UVA radiation. This heightened sensitivity allows UVA energy to exert its therapeutic effects at lower, safer doses. The interaction between psoralen and UVA light is crucial for its efficacy in treating conditions like psoriasis and vitiligo. In vitiligo, it stimulates melanocytes, the pigment-producing cells, to increase melanin synthesis in response to UVA exposure, thereby restoring skin color.

Distinction from Photodynamic Therapy

While PUVA therapy utilizes light-sensitive compounds and light exposure, it is often distinguished from photodynamic therapy (PDT). PDT is a broader category involving light-activated compounds that become toxic to targeted diseased cells. PUVA's specific mechanism, involving psoralen's interaction with DNA and its photosensitizing properties, sets it apart, although both are forms of light-based treatments.[4][5]

Procedure

Psoralen Administration

Psoralens, available in both natural and synthetic forms, are administered to sensitize the skin. This can be achieved systemically via oral medication (pills) or topically by direct application, such as soaking the affected skin in a psoralen-containing solution. The choice of administration method often depends on the extent and location of the skin condition.

UVA Exposure and Dosing

Following psoralen administration, the patient's skin is exposed to UVA light. The intensity and duration of exposure are carefully calibrated. Modern PUVA lamps, such as those utilizing LEDs, offer more intense light, potentially reducing treatment time and allowing for weaker psoralen concentrations. Treatment doses are typically initiated based on the patient's skin type and gradually increased until a therapeutic response, often indicated by mild skin redness (erythema), is observed.

The initial UVA dose is determined by the patient's skin type and sensitivity. It is progressively increased, often by small increments (e.g., 10 seconds per session), until the skin exhibits a slight pinkness, signifying a phototoxic reaction. Once this response is achieved, the UVA dose is maintained consistently. Some clinics employ a pre-treatment test to determine the Minimum Phototoxic Dose (MPD) or Minimal Erythema Dose (MED) after psoralen ingestion, using this value as the baseline for subsequent treatment sessions.

Targeted Application

For localized patches of conditions like vitiligo, psoralen can be applied directly as drops onto the affected spots. This highly targeted approach minimizes systemic exposure and associated side effects. However, for more widespread conditions, oral psoralen or immersion therapy (like PUVA bath therapy) may be necessary.

Comparison with Narrowband UVB

UVB vs. PUVA

Narrowband ultraviolet B (UVB) phototherapy, particularly at 311 nanometers, has become a more common treatment for conditions like vitiligo, largely because it eliminates the need for psoralen and is generally easier to administer over larger body surface areas. However, PUVA therapy may retain an advantage for specific areas like the hands and legs.

Penetration Depth

The rationale for PUVA's potential superiority in certain regions lies in the differing penetration depths of UVA and UVB light. UVA penetrates deeper into the skin layers compared to UVB. Since the melanocytes responsible for skin pigmentation are located deeper in the dermis of the hands and legs, UVA's greater penetration may make PUVA more effective for treating pigmentary disorders in these areas. Narrowband UVB, conversely, is largely absorbed by the stratum corneum, the outermost skin layer.

Melanin Production

Melanin, the pigment that determines skin color, is produced by melanocytes. These cells possess receptors that detect UV light, triggering melanin synthesis. Melanin serves as a natural shield, protecting the underlying skin cells from UV-induced damage. The interplay between UV light, psoralen, and melanocyte stimulation is central to the therapeutic outcomes observed in PUVA therapy.

Side Effects and Complications

Acute Side Effects

When psoralen is administered orally for extensive skin areas, patients may experience acute side effects such as nausea and itching. For individuals sensitive to oral psoralen, alternative methods like PUVA bath therapy can be considered to mitigate these gastrointestinal and dermatological reactions.

Long-Term Risks

Prolonged or repeated use of oral PUVA therapy has been associated with an increased incidence of skin cancers, notably squamous cell carcinoma.[7] This risk is attributed to the combined carcinogenic effects of UVA radiation and psoralen's interaction with DNA, which can lead to genomic instability.[citation needed]

Carcinogenic Factors

The development of squamous cell skin cancer is considered the most significant complication of long-term PUVA therapy, particularly for psoriasis treatment. Both the non-ionizing radiation of UVA light and the psoralen molecule, which can intercalate into DNA, contribute to cellular damage and potentially increase the risk of malignant transformation. Careful monitoring and adherence to treatment protocols are essential to minimize these risks.

Historical Context

Ancient Origins

The therapeutic use of light-sensitive plants and sunlight dates back millennia. Ancient Egyptians, around 2000 BC, applied the juice of the plant Ammi majus to vitiligo patches, followed by sun exposure.[8] Historical texts from the 13th century also describe similar treatments using a plant identified as A. majus, known to contain psoralen derivatives like bergapten and methoxsalen.[9]

Early Phototherapy Devices

The foundation for modern phototherapy was laid in the late 19th century. Niels Ryberg Finsen developed early, bulky phototherapy apparatuses in the 1890s to treat skin diseases with UV light. By 1900, Gustave Trouvรฉ had miniaturized these devices, creating portable light radiators for treating skin ailments.[10]

The development of modern PUVA therapy gained momentum in the mid-20th century. In the 1940s, Abdel Monem El Mofty pioneered the use of crystalline methoxsalen (8-methoxypsoralen) combined with sunlight exposure for treating vitiligo. This clinical application marked a significant step toward the standardized PUVA protocols used today for various skin conditions. Chemically synthesized psoralen and advanced phototherapy equipment became widely available from the 1970s onwards.

External Resources

Dermatological Information

For further details on phototherapy and related skin treatments, consult resources from reputable dermatological organizations.

DermNet NZ: Phototherapy (opens in new tab)

Medication Information

Information regarding specific medications used in PUVA therapy, such as psoralen derivatives, can be found through pharmaceutical databases.

RxList: Oxsoralen-Ultra (opens in new tab)

Health Policy Guidelines

Guidelines on the medical necessity and coverage of light therapies for dermatologic conditions are often published by health insurance providers.

BCBSNC Medical Policy (opens in new tab)

Teacher's Corner

Edit and Print this course in the Wiki2Web Teacher Studio

Edit and Print Materials from this study in the wiki2web studio
Click here to open the "Puva Therapy" Wiki2Web Studio curriculum kit

Use the free Wiki2web Studio to generate printable flashcards, worksheets, exams, and export your materials as a web page or an interactive game.

True or False?

Test Your Knowledge!

Gamer's Corner

Are you ready for the Wiki2Web Clarity Challenge?

Learn about puva_therapy while playing the wiki2web Clarity Challenge game.
Unlock the mystery image and prove your knowledge by earning trophies. This simple game is addictively fun and is a great way to learn!

Play now

References

References

  1.  Gustave Trouvรƒยฉ French Electrical Genius (1839รขย€ย“1902)" รขย€ย“ McFarland Books รขย€ย“ Author: Kevin Desmond pp. 162รขย€ย“-164
A full list of references for this article are available at the PUVA therapy Wikipedia page

Feedback & Support

To report an issue with this page, or to find out ways to support the mission, please click here.

Disclaimer

Important Notice Regarding Medical Information

This page has been generated by an Artificial Intelligence and is intended solely for informational and educational purposes. The content is derived from a snapshot of publicly available data and may not be entirely accurate, comprehensive, or current.

This content does not constitute medical advice. The information provided herein is not a substitute for professional medical consultation, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of information obtained from this resource.

The creators of this page are not liable for any errors or omissions, nor for any actions taken based on the information presented.